Brooktree Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Sell |
2,246
-218
| -9% | -$170K | 1.14% | 16 |
|
|
2025
Q1 | $2.04M | Sell |
2,464
-1,721
| -41% | -$1.42M | 1.53% | 13 |
|
|
2024
Q4 | $3.23M | Sell |
4,185
-21
| -0.5% | -$16.2K | 2.4% | 11 |
|
|
2024
Q3 | $3.73M | Sell |
4,206
-418
| -9% | -$370K | 3.03% | 11 |
|
|
2024
Q2 | $4.19M | Sell |
4,624
-1,208
| -21% | -$1.09M | 3.58% | 10 |
|
|
2024
Q1 | $4.54M | Sell |
5,832
-1,257
| -18% | -$978K | 3.5% | 12 |
|
|
2023
Q4 | $4.13M | Sell |
7,089
-89
| -1% | -$51.9K | 3.34% | 13 |
|
|
2023
Q3 | $3.86M | Sell |
7,178
-496
| -6% | -$266K | 3.22% | 14 |
|
|
2023
Q2 | $3.6M | Sell |
7,674
-579
| -7% | -$272K | 2.74% | 15 |
|
|
2023
Q1 | $2.83M | Sell |
8,253
-661
| -7% | -$227K | 2.21% | 17 |
|
|
2022
Q4 | $3.26M | Hold |
8,914
| – | – | 2.68% | 17 |
|
|
2022
Q3 | $2.88M | Sell |
8,914
-427
| -5% | -$138K | 2.37% | 17 |
|
|
2022
Q2 | $3.03M | Sell |
9,341
-219
| -2% | -$71K | 2.28% | 16 |
|
|
2022
Q1 | $2.74M | Sell |
9,560
-2,379
| -20% | -$681K | 1.78% | 18 |
|
|
2021
Q4 | $3.3M | Sell |
11,939
-1,054
| -8% | -$291K | 2.02% | 17 |
|
|
2021
Q3 | $3M | Sell |
12,993
-376
| -3% | -$86.9K | 1.91% | 18 |
|
|
2021
Q2 | $3.07M | Sell |
13,369
-20
| -0.1% | -$4.59K | 1.97% | 17 |
|
|
2021
Q1 | $2.5M | Sell |
13,389
-140
| -1% | -$26.2K | 1.68% | 20 |
|
|
2020
Q4 | $2.28M | Sell |
13,529
-837
| -6% | -$141K | 1.68% | 21 |
|
|
2020
Q3 | $2.13M | Sell |
14,366
-220
| -2% | -$32.6K | 1.8% | 19 |
|
|
2020
Q2 | $2.39M | Sell |
14,586
-93
| -0.6% | -$15.3K | 2.25% | 18 |
|
|
2020
Q1 | $2.04M | Hold |
14,679
| – | – | 2.36% | 17 |
|
|
2019
Q4 | $1.93M | Buy |
+14,679
| New | +$1.93M | 1.77% | 22 |
|